DE1084433B - Verfahren zur Herstellung von reinen Loesungen des Kallikrein-Inaktivators - Google Patents

Verfahren zur Herstellung von reinen Loesungen des Kallikrein-Inaktivators

Info

Publication number
DE1084433B
DE1084433B DEF28061A DEF0028061A DE1084433B DE 1084433 B DE1084433 B DE 1084433B DE F28061 A DEF28061 A DE F28061A DE F0028061 A DEF0028061 A DE F0028061A DE 1084433 B DE1084433 B DE 1084433B
Authority
DE
Germany
Prior art keywords
solution
ecm
acetone
exchanger
kie
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DEF28061A
Other languages
German (de)
English (en)
Inventor
Dr Fritz Schultz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to NL130872D priority Critical patent/NL130872C/xx
Priority to NL249700D priority patent/NL249700A/xx
Priority to NL266078D priority patent/NL266078A/xx
Application filed by Bayer AG filed Critical Bayer AG
Priority to DEF28061A priority patent/DE1084433B/de
Priority to CH226360A priority patent/CH385414A/de
Priority to GB8196/60A priority patent/GB886989A/en
Priority to BE589123A priority patent/BE589123A/fr
Priority to FR822656A priority patent/FR1290131A/fr
Priority to DEF31463A priority patent/DE1148352B/de
Publication of DE1084433B publication Critical patent/DE1084433B/de
Priority to FR836147A priority patent/FR213M/fr
Priority to CH587261A priority patent/CH426104A/de
Priority to GB2117761A priority patent/GB916932A/en
Priority to SE627361A priority patent/SE331336B/xx
Priority to NL266078A priority patent/NL140409B/xx
Priority to FR865230A priority patent/FR80105E/fr
Priority to US224939A priority patent/US3181997A/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/837—Lymph; lymph-glands; thymus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/843—Digestive system
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/848—Lungs
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/854—Glands

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
DEF28061A 1959-03-28 1959-03-28 Verfahren zur Herstellung von reinen Loesungen des Kallikrein-Inaktivators Pending DE1084433B (de)

Priority Applications (16)

Application Number Priority Date Filing Date Title
NL130872D NL130872C (US07714131-20100511-C00024.png) 1959-03-28
NL249700D NL249700A (US07714131-20100511-C00024.png) 1959-03-28
NL266078D NL266078A (US07714131-20100511-C00024.png) 1959-03-28
DEF28061A DE1084433B (de) 1959-03-28 1959-03-28 Verfahren zur Herstellung von reinen Loesungen des Kallikrein-Inaktivators
CH226360A CH385414A (de) 1959-03-28 1960-02-29 Verfahren zur Herstellung von reinen Lösungen des Kallikrein-Inaktivators
GB8196/60A GB886989A (en) 1959-03-28 1960-03-08 Process for the preparation of purified solutions of the callicrein inactivator
FR822656A FR1290131A (fr) 1959-03-28 1960-03-28 Fabrication de solutions pures d'inactivateur de la kallikréine
BE589123A BE589123A (fr) 1959-03-28 1960-03-28 Fabrication de solutions pures d'inactivateur de la Kallikréine.
DEF31463A DE1148352B (de) 1959-03-28 1960-06-18 Verfahren zur Herstellung von reinen Loesungen des Kallikrein-Inaktivators
FR836147A FR213M (fr) 1959-03-28 1960-08-18 Inactivateur de la kallikréine contre les maladies du pancréas.
CH587261A CH426104A (de) 1959-03-28 1961-05-19 Verfahren zur Herstellung von reinen Lösungen des Kallikrein-Inaktivators
GB2117761A GB916932A (en) 1959-03-28 1961-06-12 Process for the production of pure solutions of callicrein inactivator
SE627361A SE331336B (US07714131-20100511-C00024.png) 1959-03-28 1961-06-15
NL266078A NL140409B (nl) 1959-03-28 1961-06-16 Werkwijze ter bereiding van zuivere oplossingen van de inactivator van kallikreine en hieruit bereide farmaceutische preparaten.
FR865230A FR80105E (fr) 1959-03-28 1961-06-16 Fabrication de solutions pures d'inactivateur de la kallikréine
US224939A US3181997A (en) 1959-03-28 1962-09-20 Process for preparing purified solutions of kallikrein inactivator

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DEF28061A DE1084433B (de) 1959-03-28 1959-03-28 Verfahren zur Herstellung von reinen Loesungen des Kallikrein-Inaktivators

Publications (1)

Publication Number Publication Date
DE1084433B true DE1084433B (de) 1960-06-30

Family

ID=7092726

Family Applications (1)

Application Number Title Priority Date Filing Date
DEF28061A Pending DE1084433B (de) 1959-03-28 1959-03-28 Verfahren zur Herstellung von reinen Loesungen des Kallikrein-Inaktivators

Country Status (7)

Country Link
US (1) US3181997A (US07714131-20100511-C00024.png)
BE (1) BE589123A (US07714131-20100511-C00024.png)
CH (1) CH385414A (US07714131-20100511-C00024.png)
DE (1) DE1084433B (US07714131-20100511-C00024.png)
FR (1) FR1290131A (US07714131-20100511-C00024.png)
GB (1) GB886989A (US07714131-20100511-C00024.png)
NL (2) NL249700A (US07714131-20100511-C00024.png)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE754278A (fr) * 1969-08-02 1971-02-01 Bayer Ag Procede d'utilisation d'inhibiteurs biologiques de proteases comme desodorisants
US3951939A (en) * 1972-01-08 1976-04-20 Behringwerke Aktiengesellschaft Polypeptides, process for their manufacture and their use as polyvalent isoinhibitors
JPS5544726B2 (US07714131-20100511-C00024.png) * 1973-05-17 1980-11-13
US4190573A (en) * 1974-02-14 1980-02-26 Behringwerke Aktiengesellschaft Process for the isolation of the polyvalent proteinase inhibitor

Also Published As

Publication number Publication date
US3181997A (en) 1965-05-04
FR1290131A (fr) 1962-04-13
NL249700A (US07714131-20100511-C00024.png)
GB886989A (en) 1962-01-10
BE589123A (fr) 1960-07-18
NL130872C (US07714131-20100511-C00024.png)
CH385414A (de) 1964-12-15

Similar Documents

Publication Publication Date Title
DE1084433B (de) Verfahren zur Herstellung von reinen Loesungen des Kallikrein-Inaktivators
DE1076888B (de) Verfahren zur Gewinnung atmungsfoerdernder Wirkstoffe fuer therapeutische Zwecke
AT215596B (US07714131-20100511-C00024.png)
AT200257B (US07714131-20100511-C00024.png)
DE719026C (de) Verfahren zur Herstellung von Praeparaten, die das Kreislaufhormon Kallikrein enthalten
DE2757377A1 (de) Verfahren zum stabilisieren, konzentrieren und reinigen von insulin
AT225349B (de) Verfahren zur Herstellung von reinen Lösungen des Kallikrein-Inaktivators
DE708939C (de) Verfahren zur Herstellung gonadotroper Hormone aus waessrigen Ausgangsloesungen
DE565065C (de) Verfahren zur getrennten Gewinnung einer blutdruckerhoehenden Substanz und einer aufden Uterusmuskel zusammenziehend wirkenden Substanz aus dem Hypophysenhinterlappen
DE701714C (de) Verfahren zur Herstellung haltbarer wasserloeslicher Trockenpraeparate des Kreislaufhormons aus Bauchspeicheldruesen von Tieren
DE1161658B (de) Gewinnung des Kallikrein-Inaktivators aus Insulin-Abfaellen
DE859514C (de) Verfahren zur Gewinnung antianaemischer Wirkstoffe aus Leber
DE631790C (de) Verfahren zur Herstellung von genuinen, kristallisierten Digitalisglucosiden
DE685144C (de) Verfahren zur Darstellung physiologisch wirksamer Stoffe aus Nebennieren
DE954284C (de) Verfahren zur Gewinnung eines Kallikrein-Inaktivators
DE657129C (de) Verfahren zur Herstellung von Loesungen oder Extrakten aus Bakterien, Pollen oder sonstigen pflanzlichen Zellen
DE605175C (de) Verfahren zur Herstellung von wasserloeslichen, physiologisch wirksamen Stoffen
DE947193C (de) Verfahren zur Gewinnung von Vitamin B
DE626274C (de) Verfahren zur Gewinnung physiologisch wirksamer Substanzen aus Muskeln
DE651435C (de) Verfahren zur Gewinnung eines Vitaminpraeparates
DE579820C (de) Verfahren zur Gewinnung weiblicher Sexualhormone in kristallisierter Form
DE708839C (de) Verfahren zur Herstellung gonadotroper Hormone aus waessrigen Ausgangsloesungen
DE1617948C (de) Verfahren zur Herstellung eines das retikuloendothelialen Systems stimulieren den Stoffs
DE957160C (de) Verfahren zur Herstellung von biologisch aktiven Zubereitungen
DE1467773A1 (de) Polypeptid und Verfahren zur Herstellung desselben